Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERα pathway

Journal of Steroid Biochemistry and Molecular Biology

Volumn 108, Issue 1-2, 2008, Pages 64-71

  Lau, Wai Sum ^a,b   Chan, Robbie Yat Kan ^a,b   Guo, De An ^c   Wong, Man Sau ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b State Key Laboratory of Chinese Medicine and Molecular Pharmacology   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

ER ; Ginsenoside Rg1; Phytoestrogens

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GINSENOSIDE RG 1; PHYTOESTROGEN;

ARTICLE; CELL ACTIVATION; CELL STRAIN HEK293; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION;

BREAST NEOPLASMS; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION; GENES, REPORTER; GINSENOSIDES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIGANDS; LUCIFERASES; PHOSPHORYLATION; PHYTOESTROGENS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

PANAX GINSENG;

EID: 38649129855     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.06.005     Document Type: Article

References (33)

1. Ramalho A.C., Couttet P., Baudoin C., Morieux C., Graulet A.M., Vernejoul M.C., and Cohen-Solal M.E. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures. Eur. Cytokine Netw. 13 (2002) 39-45
2. Persson I., Thurfjell E., and Holberg L. Effect of estrogen and estrogen-progestin replacement regimes on mammographic breast parenchymal density. J. Clin. Oncol. 15 (1997) 3201-3207
3. Mackey R., and Eden J. Phytoestrogens and the menopause. Climacteric 1 (1998) 302-308
4. Kronenberg F., and Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann. Intern. Med. 137 (2002) 805-813
5. Huang K.C. The Pharmacology of Chinese Herbs (1999), CRC Press, Boca Raton, FL
6. Lee Y.J., Jin Y.R., Lim W.C., Park W.K., Cho J.Y., Jang S., and Lee S.K. Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Arch. Pharm. Res. 26 (2003) 58-63
7. Chan R.Y.K., Chen W.F., Guo A.I., Dong D., and Wong M.S. Estrogen-like effects of ginsenoside Rg1. J Clin. Endocrinol. Metab. 87 (2002) 3691-3695
8. Chen W.F., Lau W.S., Cheung P.Y., Guo D.A., and Wong M.S. Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1. Br. J. Pharmacol. 147 (2006) 542-551
9. Enmark E., and Gustafsson J.A. Oestrogen receptors-an overview. J. Intern. Med. 246 2 (1999) 133-138
10. Brigitte G., and Johannes W. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 166 (2001) 79-89
11. Lees J.A., Fawell S.E., and Parker M.G. Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res. 17 14 (1989) 5477-5488
12. Tora L., White J., Bron C., Tasset D., Webster N., and Scheer E. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59 (1989) 477-487
13. Tzukerman M.T., Esty A., Santiso-Mere D., Danielian P., Parker M.G., and Stein R.B. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8 (1994) 21-30
14. Lee Y.J., Chang E., Lee K.Y., Lee Y.H., Huh B., and Lee S.K. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol. Cell. Endocrinol. 133 (1997) 135-140
15. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., and Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 (1995) 1491-1494
16. Karas R.H., Gauer E.A., Bieber H.E., Baur W.E., and Mendelsohn M.E. Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway. J. Clin. Invest. 101 (1998) 2851-2861
17. Catalano S., Mauro L., Marsico S., Giordano C., Rizza P., Rago V., Montanaro D., Maggiolini M., Panno M.L., and Ando S. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J. Biol. Chem. 279 (2004) 19908-19915
18. Deborah A.L. Estrogen receptor phosphorylation. Steroids 68 (2003) 1-9
19. Chen D., Washbrook E., Sarwar N., Bates G.J., Pace P.E., Thirunuvakkarasu V., Taylor J., Epstein R.J., Fuller-Pace F.V., Egly J.M., Coombes R.C., and Ali S. Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene 21 (2002) 4921-4931
20. Chen W.F., and Wong M.S. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J. Clin. Endocrinol. Metab. 89 (2004) 2351-2359
21. Wakeling A.E., Dules M., and Bowler J. Apotent specific pure antiestrogen with clinical potential. Cancer Res. 51 (1991) 3867-3873
22. Punnonen R., and Lukola A. Oestrogen-like effect of ginseng. Br. Med. J. 281 (1980) 1110
23. Cassidy A. Potential tissue selectivity of dietary phytoestrogens and estrogens. Curr. Opin. Lipidol. 10 (1999) 47-52
24. Martin P.M., Horwitz K.B., Ryan D.S., and McGuire W.L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103 5 (1978) 1860-1867
25. Bunone G., Briand P.A., Miksicek R.J., and Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15 (1996) 2174-2183
26. Lu Q., Ebling H., Mittler J., Baur W.E., and Karas R.H. MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor α. FEBS Lett. 516 (2002) 1-8
27. Cho J., Park W., Lee S., Ahn W., and Lee Y. Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-α and -β, independent of ligand binding. J. Clin. Endocrinol. Metab. 89 (2004) 3510-3515
28. Mueller S.O., Simon S., Chae K., Metzler M., and Korach S.K. Phytoestrogens and their human metabolisms show distinct agonistic and antagonistic properties on estrogen receptor (ER) α and ERβ in human cells. Toxicol. Sci. 80 1 (2004) 14-25
29. Mueller S.O. Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens. J. Chromatogr. B 777 (2002) 155-165
30. Couse J.F., and Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 20 (1999) 358-417
31. Radad K., Gille G., Moldzio R., Saito H., Rausch W.D., and Ginsenoside. Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res. 1021 (2004) 42-53
32. Chen X.C., Fang F., Zhu Y.G., Chen L.M., Zhou Y.C., and Chen Y. Protective effect of ginsenoside Rg1 on MPP+-induced apotosis in SHSY5Y cells. J. Neural Transm. 110 (2003) 835-845
33. Gardona-Gomez G.P., Mendez P., Doncarlos L.L., Azcoitia I., and Garcia-Segura L.M. Interaction of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications. J. Steroid. Biochem. Mol. Biol. 83 (2002) 211-217